XML 49 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Number of awards, beginning balance 62,469  
Weighted avg exercise price per share, beginning balance $ 9.05  
Weighted avg grant date fair value per share, beginning balance $ 8.07  
Weighted avg. remaining contractual life (in years), outstanding 3 years 6 months 18 days 4 years 4 months 13 days
Aggregate intrinsic value, beginning balance $ 334,769  
Number of awards, granted  
Weighted avg exercise price per share, granted  
Weighted avg grant date fair value per share, granted  
Number of awards, exercised (10,640)  
Weighted avg exercise price per share, exercised $ 7.42  
Weighted avg grant date fair value per share, exercised $ 6.99  
Weighted avg. remaining contractual life (in years), exercised 3 years 6 months 3 days  
Number of awards, expired/forfeited  
Weighted avg exercise price per share, expired/forfeited  
Weighted avg grant date fair value per share, expired/forfeited  
Number of awards, ending balance 51,829 62,469
Weighted avg exercise price per share, ending balance $ 9.36 $ 9.05
Weighted avg grant date fair value per share, ending balance $ 8.30 $ 8.07
Aggregate intrinsic value, ending balance $ 254,605 $ 334,769
Number of awards exercisable, ending balance 51,829  
Weighted avg. exercise price per share exercisable, ending balance $ 9.36  
Weighted avg. grant date fair value per share exercisable, ending balance $ 8.30  
Weighted avg. remaining contractual life (in years), exercisable 3 years 6 months 18 days  
Aggregate intrinsic value, exercisable ending balance $ 254,605  
Number of awards unvested, ending balance  
Weighted avg. exercise price per share unvested, ending balance  
Weighted avg. grant date fair value per share unvested, ending Balance  
Aggregate intrinsic value, unvested ending balance